New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling

doi:10.1016/j.semcancer.2018.02.008

Title: New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling

Abstract

RAS is the most frequently mutated gene across human cancers, but developing inhibitors of mutant RAS has proven to be challenging. Given the difficulties of targeting RAS directly, drugs that impact the other components of pathways where mutant RAS operates may potentially be effective. However, the system-level features, including different localizations of RAS isoforms, competition between downstream effectors, and interlocking feedback and feed-forward loops, must be understood to fully grasp the opportunities and limitations of inhibiting specific targets. Mathematical modeling can help us discern the system-level impacts of these features in normal and cancer cells. New technologies enable the acquisition of experimental data that will facilitate development of realistic models of oncogenic RAS behavior. In light of the wealth of empirical data accumulated over decades of study and the advancement of experimental methods for gathering new data, modelers now have the opportunity to advance progress toward realization of targeted treatment for mutant RAS-driven cancers.

Authors:

Erickson, Keesha E. ^[1]; Rukhlenko, Oleksii S. ^[2]; Posner, Richard G. ^[3]; Hlavacek, William S. ^[4]; Kholodenko, Boris N. ^[2]

Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
Univ. College Dublin (United Kingdom)
Northern Arizona Univ., Flagstaff, AZ (United States)
Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Univ. of New Mexico Comprehensive Cancer Center, Albuquerque, NM (United States)

Publication Date:: 2018-03-05

Research Org.:: Los Alamos National Lab. (LANL), Los Alamos, NM (United States)

Sponsoring Org.:: USDOE

OSTI Identifier:: 1425769

Report Number(s):: LA-UR-17-31291
Journal ID: ISSN 1044-579X

Grant/Contract Number:: AC52-06NA25396

Resource Type:: Accepted Manuscript

Journal Name:: Seminars in Cancer Biology

Additional Journal Information:: Journal Volume: 54; Journal ID: ISSN 1044-579X

Publisher:: Elsevier

Country of Publication:: United States

Language:: English

Subject:: 59 BASIC BIOLOGICAL SCIENCES; Biological Science; RAS; ERK cascade; Mechanistic modeling; Mathematical modeling; Systems biology

Citation Formats


                    Erickson, Keesha E., Rukhlenko, Oleksii S., Posner, Richard G., Hlavacek, William S., and Kholodenko, Boris N. New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling.  United States: N. p., 2018. 
        Web.  doi:10.1016/j.semcancer.2018.02.008.

Copy to clipboard


                    Erickson, Keesha E., Rukhlenko, Oleksii S., Posner, Richard G., Hlavacek, William S., & Kholodenko, Boris N. New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling.  United States.  doi:10.1016/j.semcancer.2018.02.008.

Copy to clipboard


                    Erickson, Keesha E., Rukhlenko, Oleksii S., Posner, Richard G., Hlavacek, William S., and Kholodenko, Boris N. Mon .  
        "New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling".  United States.  doi:10.1016/j.semcancer.2018.02.008.  https://www.osti.gov/servlets/purl/1425769.

Copy to clipboard


                    
@article{osti_1425769,

  title        = {New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling},

  author       = {Erickson, Keesha E. and Rukhlenko, Oleksii S. and Posner, Richard G. and Hlavacek, William S. and Kholodenko, Boris N.},

  abstractNote = {RAS is the most frequently mutated gene across human cancers, but developing inhibitors of mutant RAS has proven to be challenging. Given the difficulties of targeting RAS directly, drugs that impact the other components of pathways where mutant RAS operates may potentially be effective. However, the system-level features, including different localizations of RAS isoforms, competition between downstream effectors, and interlocking feedback and feed-forward loops, must be understood to fully grasp the opportunities and limitations of inhibiting specific targets. Mathematical modeling can help us discern the system-level impacts of these features in normal and cancer cells. New technologies enable the acquisition of experimental data that will facilitate development of realistic models of oncogenic RAS behavior. In light of the wealth of empirical data accumulated over decades of study and the advancement of experimental methods for gathering new data, modelers now have the opportunity to advance progress toward realization of targeted treatment for mutant RAS-driven cancers.},

  doi          = {10.1016/j.semcancer.2018.02.008},

  journal      = {Seminars in Cancer Biology},

  number       = ,

  volume       = 54,

  place        = {United States},

  year         = {2018},

  month        = {3}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Accepted Manuscript (DOE)

Publisher's Version of Record

DOI: 10.1016/j.semcancer.2018.02.008

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 1 work

Citation information provided by
Web of Science

Figures / Tables:

Figure 1: The RAS activation cycle. RAS can bind either GTP or GDP, and is active when bound to GTP. In the active configuration, it is able to interact with downstream effectors. RAS activation/deactivation can occur through multiple processes. Processes of interest are labeled with circled numbers: 1 shows freemore »

All figures and tables (7 total)

Save / Share:

Export Metadata

Save to My Library

Figures / Tables found in this record:

Figures/Tables have been extracted from DOE-funded journal article accepted manuscripts.

Similar records in OSTI.GOV collections:

Molecular interaction between K-Ras and H-REV107 in the Ras signaling pathway

Journal Article Han, Chang Woo ; Jeong, Mi Suk ; Jang, Se Bok, E-mail: sbjang@pusan.ac.kr - Biochemical and Biophysical Research Communications

Ras proteins are small GTPases that serve as master moderators of a large number of signaling pathways involved in various cellular processes. Activating mutations in Ras are found in about one-third of cancers. H-REV107, a K-Ras binding protein, plays an important role in determining K-Ras function. H-REV107 is a member of the HREV107 family of class II tumor suppressor genes and a growth inhibitory Ras target gene that suppresses cellular growth, differentiation, and apoptosis. Expression of H-REV107 was strongly reduced in about 50% of human carcinoma cell lines. However, the specific molecular mechanism by which H-REV107 inhibits Ras is stillmore »« less
DOI: 10.1016/J.BBRC.2017.07.120
Ras-GTP dimers activate the mitogen-activated protein kinase (MAPK) pathway

Journal Article Nan, Xiaolin ; Tamgüney, Tanja M. ; Collisson, Eric A. ; ... - Proceedings of the National Academy of Sciences of the United States of America

Rat sarcoma (Ras) GTPases regulate cell proliferation and survival through effector pathways including Raf-MAPK, and are the most frequently mutated genes in human cancer. Although it is well established that Ras activity requires binding to both GTP and the membrane, details of how Ras operates on the cell membrane to activate its effectors remain elusive. Efforts to target mutant Ras in human cancers to therapeutic benefit have also been largely unsuccessful. Here we show that Ras-GTP forms dimers to activate MAPK. We used quantitative photoactivated localization microscopy (PALM) to analyze the nanoscale spatial organization of PAmCherry1-tagged KRas 4B (hereafter referredmore »« less
Cited by 55
DOI: 10.1073/pnas.1509123112

Full Text Available
K-Ras(G12D)-selective inhibitory peptides generated by random peptide T7 phage display technology

Journal Article Sakamoto, Kotaro ; Kamada, Yusuke ; Sameshima, Tomoya ; ... - Biochemical and Biophysical Research Communications

Amino-acid mutations of Gly{sup 12} (e.g. G12D, G12V, G12C) of V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (K-Ras), the most promising drug target in cancer therapy, are major growth drivers in various cancers. Although over 30 years have passed since the discovery of these mutations in most cancer patients, effective mutated K-Ras inhibitors have not been marketed. Here, we report novel and selective inhibitory peptides to K-Ras(G12D). We screened random peptide libraries displayed on T7 phage against purified recombinant K-Ras(G12D), with thorough subtraction of phages bound to wild-type K-Ras, and obtained KRpep-2 (Ac-RRCPLYISYDPVCRR-NH{sub 2}) as a consensus sequence. KRpep-2 showedmore »« less
DOI: 10.1016/J.BBRC.2017.01.147
Structure of the Dominant Negative S17N Mutant of Ras

Journal Article Nassar, N. ; Singh, K ; Garcia-Diaz, M - Biochemistry

The use of the dominant negative mutant of Ras has been crucial in elucidating the cellular signaling of Ras in response to the activation of various membrane-bound receptors. Although several point mutants of Ras exhibit a dominant negative effect, the asparagine to serine mutation at position 17 (S17N) remains the most popular and the most effective at inhibiting the activation of endogenous Ras. It is now widely accepted that the dominant negative effect is due to the ability of the mutant to sequester upstream activators and its inability to activate downstream effectors. Here, we present the crystal structure of RasS17Nmore »« less
DOI: 10.1021/bi9020742
A human protein selected for interference with Ras function interacts directly with Ras and competes with Raf1

Journal Article Han, L. ; Colicelli, J. - Molecular and Cellular Biology

The overexpression of some human proteins can cause interference with the Ras signal transduction pathway in the yeast Saccharomyces cerevisiae. The functional block is located at the level of the effector itself, since these proteins do not suppress activating mutations further downstream in the same pathway. We now demonstrate, with in vivo and in vitro experiments, that the protein encoded by one human cDNA (clone 99) can interact directly with yeast Ras2p and with human H-Ras protein, and we have named this gene rin1 (Ras interaction/interference). The interaction between Ras and Rin1 is enhanced when Ras is bound to GTP.more »« less
DOI: 10.1128/MCB.15.3.1318

Similar Records